N.M. Admin. Code § 16.19.26.11 - TB TESTING
A.
Protocol:
(1) Prescriptive
authority for Tuberculosis (TB) testing shall be exercised solely in accordance
with the written protocol for TB testing drug therapy approved by the
board.
(2) Any pharmacist
exercising prescriptive authority for TB testing must maintain a current copy
of the written protocol for TB testing approved by the board.
B.
Education and
training:
(1) The pharmacist must
successfully complete training as specified by the New Mexico department of
health tuberculosis department provided by:
(a) the department of health or;
(b) a similar health authority or
professional body approved by the board.
(2) Continuing education: Any pharmacist
exercising prescriptive authority for TB testing shall complete continuing
education as specified by the centers for disease control.
C.
Authorized drugs:
(1) TB skin antigen serum(s).
(2) Prescriptive authority for TB testing
shall be limited to those drugs delineated in the written protocol approved by
the board.
D.
Records:
(1) The prescribing
pharmacist must generate a written or electronic prescription for any TB test
administered.
(2) Informed consent
must be documented in accordance with the approved protocol for TB testing and
a record of such consent maintained in the pharmacy for a period of at least
three years.
E.
Notification: Upon signed consent of the patient, the pharmacist
shall notify the patient's designated physician or primary care provider and
the department of health of any positive TB test.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.